Skip to main content
$9.14 -$0.06 (-0.6%)

01:00 PM EST on 11/26/21

23andMe Holding Co. (NASDAQ:ME)

CAPS Rating: 2 out of 5

23andMe, Inc., headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, 23andMe's mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple Food and Drug Administration authorizations for genetic health risk reports. 23andMe has created the world's largest crowdsourced platform for genetic research, with 80% of its customers electing to participate.

Current Price $9.14 Mkt Cap $4.0B
Open $9.21 P/E Ratio 0.00
Prev. Close $9.14 Div. (Yield) $0.00 (0.0%)
Daily Range $8.87 - $9.64 Volume 13,135
52-Wk Range $7.01 - $18.16 Avg. Daily Vol. 3,255,684

Caps

How do you think NASDAQ:ME will perform against the market?

Add Stock to CAPS Watchlist

All Players

29 Outperform
2 Underperform
 

All-Star Players

2 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ME Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

NHWeston102 (76.61)
Submitted November 06, 2021

Almost doubled after buying on-line health service, Lemonaid. A friend of mine used their platform and was extremely impressed with both their ancestral lineage DNA detection and also their very detailed genetic health analysis. Lets see where this… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:ME VS S&P 500 (SPY)

NASDAQ:ME Summary

  • Sector:
  • Industry:
  • Tags:

Fools bullish on NASDAQ:ME are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ME.

Recs

0
Member Avatar RNInvestor (< 20) Submitted: 11/16/2021 7:29:03 AM : Outperform Start Price: $10.84 NASDAQ:ME Score: -13.90

The pivot into the utilization of genetic data to create novel therapeutics is promising. In addition to the consumer business that is already in place drug approvals could significantly drive up revenue for very little cost to the company.

Recs

1
Member Avatar NHWeston102 (76.61) Submitted: 11/6/2021 3:21:45 PM : Outperform Start Price: $13.33 NASDAQ:ME Score: -29.15

Almost doubled after buying on-line health service, Lemonaid. A friend of mine used their platform and was extremely impressed with both their ancestral lineage DNA detection and also their very detailed genetic health analysis. Lets see where this goes.

Recs

1
Member Avatar KPowersUSMC (25.94) Submitted: 10/21/2021 2:11:43 PM : Outperform Start Price: $10.30 NASDAQ:ME Score: -12.75

As world population grows,= more customers

Leaderboard

Find the members with the highest scoring picks in ME.

Score Leader

chammond55

chammond55 (95.16) Score: +24.06

The Score Leader is the player with the highest score across all their picks in ME.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
chammond55 95.16 11/12/2021 Underperform 5Y $12.26 -25.45% -1.39% +24.06 0 Comment
IPO2019 57.92 10/7/2021 Outperform 5Y $7.86 +16.28% +4.35% +11.94 0 Comment
JCDaniel < 20 8/12/2021 Outperform 5Y $8.20 +11.46% +3.46% +8.00 0 Comment
AustinGreenTech 21.21 10/4/2021 Outperform 5Y $8.25 +10.79% +7.00% +3.79 0 Comment
cruisin25 53.37 8/23/2021 Outperform 3M $8.59 +6.40% +2.67% +3.73 0 Comment
jscm86 59.00 9/2/2021 Outperform 5Y $8.76 +4.34% +1.21% +3.13 0 Comment
Byron111 96.78 8/23/2021 Outperform 5Y $8.90 +2.70% +3.10% -0.41 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. TMFJoryko 99.07 8/9/2021 Outperform 5Y $8.87 +3.04% +3.73% -0.69 0 Comment
GoldMiner20 45.59 9/30/2021 Outperform 5Y $8.75 +4.46% +5.26% -0.81 0 Comment
sgengine7 < 20 9/22/2021 Outperform 5Y $8.99 +1.67% +4.85% -3.18 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ME.